MetaCap

Addex Therapeutics Ltd ADR (ADXN)

NASDAQ: ADXNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.47+0.07 (+2.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ADXN stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$7.56
52-week range
2.56 – 10.43
Day range
3.24 – 3.53
Volume / Avg
18.22K / 383.35K
Beta
—
Next earnings
Nov 23, 2026

52-week range

$2.56$10.43

ADXN stock today

Addex Therapeutics (ADXN) closed at $3.47 on Nov 20, up 2.06% (+$0.07), versus the S&P 500's 3.70% decline. Trading was light, with 18.22K shares changing hands, about 5% of the average daily volume. Shares are 66.7% below their 52-week high of $10.43 and 35.5% above the 52-week low of $2.56, near the bottom of the past year's range.

Addex Therapeutics has posted a net loss over the last twelve months (EPS of -$7.56), so its P/E ratio is not meaningful. The company is scheduled to report Sep/2026 results on Nov 23 before the market opens.

Summary generated from market data by MetaCap's automated system. Methodology

About Addex Therapeutics

Company profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Timothy Mark Dyer
Headquarters
Geneva
Employees
3

Earnings

Earnings history
Next report
Nov 23, 2026

ADXN news

All ADXN news

Addex Therapeutics peers

Health Care sector
ADXN peer companies
CompanyPrice% ChgMarket capCompare
ENVBEnveric Biosciences Inc.1.35-4.26%$6.04Mvs ADXN
XCURExicure Inc.0.9001-12.82%$5.89Mvs ADXN
ACXPAcurx Pharmaceuticals Inc.1.04+0.97%$6.30Mvs ADXN
KYNBKyntra Bio Inc.1.56-13.33%$6.32Mvs ADXN
GTBPGT Biopharma Inc.2.96-6.92%$6.33Mvs ADXN
FBLGFibroBiologics Inc.0.705-15.06%$6.34Mvs ADXN
TPSTTempest Therapeutics Inc.0.287-6.18%$5.74Mvs ADXN
LGVNLongeveron Inc. Class A1.66-8.79%$5.60Mvs ADXN

Indexes, lists and sector

Addex Therapeutics stock FAQ

What is Addex Therapeutics's stock price today?

ADXN last traded at $3.47 as of Nov 20, 4:00 PM EST, up 2.06% on the day. Prices are delayed at least 15 minutes.

When is Addex Therapeutics's next earnings date?

Addex Therapeutics is expected to report earnings on Monday, November 23, 2026.

Who is Addex Therapeutics's CEO?

Mr. Timothy Mark Dyer is the chief executive officer of Addex Therapeutics Ltd ADR, which has about 3 employees.

What is the ADXN 52-week high?

The 52-week high for ADXN is $10.43 and the 52-week low is $2.56. The stock is currently 66.7% below its high.

Compare ADXN